{{Cite journal| doi = 10.1111/jth.13810| issn = 1538-7836 (Electronic) 1538-7836 (Linking)| volume = 15| issue = 11| pages = 2165–2175| last1 = Nagler| first1 = M.| last2 = Angelillo-Scherrer| first2 = A.| last3 = Mean| first3 = M.| last4 = Limacher| first4 = A.| last5 = Abbal| first5 = C.| last6 = Righini| first6 = M.| last7 = Beer| first7 = J. H.| last8 = Osterwalder| first8 = J.| last9 = Frauchiger| first9 = B.| last10 = Aschwanden| first10 = M.| last11 = Matter| first11 = C. M.| last12 = Kucher| first12 = N.| last13 = Cornuz| first13 = J.| last14 = Banyai| first14 = M.| last15 = Husmann| first15 = M.| last16 = Staub| first16 = D.| last17 = Mazzolai| first17 = L.| last18 = Hugli| first18 = O.| last19 = Rodondi| first19 = N.| last20 = Aujesky| first20 = D.| title = Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists| journal = J Thromb Haemost| date = 2017-08-24| pmid = 28834238}}